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Abstract  23 
Sulfatides and gangliosides are raft-associated glycolipids essential for maintaining myelinated nerve 24 
integrity. Mice deficient in sulfatide (cerebroside sulfotransferase knockout, CST-/-) or complex 25 
gangliosides (β-1,4-N-acetylegalactosaminyltransferase1 knockout, GalNAc-T-/-) display prominent 26 
disorganization of proteins at the node of Ranvier (NoR) in early life, and age-dependent 27 
neurodegeneration. Loss of neuronal rather than glial complex gangliosides underpins the GalNAc-T-28 
/- phenotype, as shown by neuron or glial-specific rescue, whereas sulfatide is principally expressed 29 
and functional in glial membranes. The similarities in NoR phenotype of CST-/-, GalNAc-T-/- and axo-30 
glial protein deficient mice suggests these glycolipids stabilise membrane proteins including 31 
neurofascin155 (NF155) and myelin-associated glycoprotein (MAG) at axo-glial junctions. To assess 32 
the functional interactions between sulfatide and gangliosides, CST-/- and GalNAc-T-/- genotypes were 33 
interbred. CST-/-x GalNAc-T-/- mice develop normally to P10, but all die between P20-P25, coinciding 34 
with peak myelination. Ultrastructural, immunohistological and biochemical analysis of either sex 35 
reveals widespread axonal degeneration and disruption to the axo-glial junction at the NoR. In 36 
addition to sulfatide-dependent loss of NF155, CST-/-x GalNAc-T-/- mice exhibited a major reduction in 37 
MAG protein levels in CNS myelin, compared to wild type and single lipid deficient mice. The CST-/-x 38 
GalNAc-T-/- phenotype was fully restored to that of CST-/- mice by neuron-specific expression of 39 
complex gangliosides, but not by their glial-specific expression nor by the global expression of a-40 
series gangliosides. These data indicate that sulfatide and complex b-series gangliosides on the glial 41 
and neuronal membranes respectively act in concert to promote NF155 and MAG in maintaining the 42 
stable axo-glial interactions essential for normal nerve function.   43 
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Significance Statement  44 
Sulfatides and complex gangliosides are membrane glycolipids with important roles in maintaining 45 
nervous system integrity. Node of Ranvier maintenance in particular requires stable 46 
compartmentalisation of multiple membrane proteins. The axo-glial adhesion molecules neurofascin 47 
155 and myelin-associated glycoprotein require membrane microdomains containing either 48 
sulfatides or complex gangliosides to localise and function effectively. The co-operative roles of 49 
these microdomains and associated proteins are unknown. Here we show vital interdependent roles 50 
for sulfatides and complex gangliosides as double (but not single) deficiency causes a rapidly lethal 51 
phenotype in early age. These findings suggests that sulfatides and complex gangliosides on 52 
opposing axo-glial membranes are responsible for essential tethering of the axo-glial junction 53 
proteins, neurofascin155 and myelin-associated glycoprotein that interact to maintain the nodal 54 
complex.  55 
 4 
 
Introduction 56 
Gangliosides are enriched in lipid rafts (Simons and Toomre, 2000), involved in the topographical 57 
organisation of membrane proteins (Jackman et al., 2009; Sonnino et al., 2014; Sonnino et al., 2015). 58 
Complex ganglioside biosynthesis requires β-1,4-N-acetylegalactosaminyltransferase 1, GalNAc-T 59 
enzyme activity (Figure 1A) with ganglioside expression being widespread in both neuronal and glial 60 
membranes.  Sulfatide, 3-O-sulfogalactosylceramide,  synthesised from galactocerebroside (GalC) by 61 
cerebroside sulfotransferase enzyme (CST, Figure 1A) is enriched in the outer leaflet of the myelin 62 
and uncompacted glial membranes (Ishizuka, 1997), small amounts being present in neurons and 63 
astrocytes (Eckhardt, 2008). Evidence indicates that both sulfatide and complex gangliosides are 64 
crucial for the maintenance and stability, rather than the developmental formation of nervous 65 
system domains (Takamiya et al., 1996; Honke et al., 2002; Sturgill et al., 2012). Mice deficient in 66 
these lipids thus develop relatively normally, before showing age-dependent degeneration 67 
(Takamiya et al., 1996; Honke et al., 2002). Evidence indicates that these glycolipids are essential for 68 
stabilising the normal arrangement of axo-glial interactions, particularly at the paranodal region of 69 
the node of Ranvier (NoR). Mice deficient for GalC and sulfatide (Dupree et al., 1999), sulfatide alone 70 
(Ishibashi et al., 2002; Marcus et al., 2006; Hoshi et al., 2007) or complex gangliosides (Susuki et al., 71 
2007) have prominently disrupted paranodes. The paranode in both the PNS and CNS  tethers and 72 
seals the abutted axon and glial membranes between the node and juxtaparanode (Garcia-Fresco et 73 
al., 2006; Susuki et al., 2013), thereby maintaining voltage-gated nodal sodium (Nav) and 74 
juxtaparanodal potassium (Kv) channel clustering and segregation, essential for normal conduction 75 
(Salzer, 1997; Poliak and Peles, 2003). The importance of appropriate expression and localisation of 76 
the paranodal proteins in stabilising Nav channel clusters is also revealed in paranodal protein 77 
knockout mice. Thus deficiency in contactin, contactin-associated protein (Caspr) or neurofascin (NF) 78 
155 leads to progressive paranodal defects from P10 and subsequent axon degeneration, with most 79 
mice dying by P21 (Bhat et al., 2001; Boyle et al., 2001; Pillai et al., 2009). Significantly, while these 80 
adhesion complex proteins comprise the physical adhesion barrier at the paranode, associated 81 
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glycolipid molecules appear to be required for their localisation and stabilisation, likely by the 82 
targeting and transportation of adhesion molecules in lipid rafts. In support of this Schafer et al. 83 
(2004), showed a reduction in raft-associated NF155 and paranodal localisation in sulfatide and GalC 84 
deficiency, thereby limiting its co-clustering function with axo-glial partners. Additionally, extraction 85 
studies implicated sulfatide-containing lipid rafts as anchors for the axo-glial adhesion molecule 86 
myelin-associated glycoprotein (MAG), as well as NF155 (Pomicter et al., 2013).  87 
Complex gangliosides are also an important lipid raft component required for paranode stabilisation, 88 
as shown by disorganisation of paranodal proteins in GalNAc-T-/- mice (Susuki et al., 2007). As 89 
gangliosides are present in both neuronal and glial membranes, their principal site of action in 90 
paranodal stabilisation cannot be presumed. To address this, we demonstrated that loss of neuronal 91 
complex gangliosides underpins the GalNAc-T-/- phenotype as selective reintroduction of complex 92 
ganglioside expression in neuronal but not glial membranes rescues the paranodal phenotype (Yao 93 
et al., 2014). Complex gangliosides GT1b and GD1a, both prominently expressed on the axonal 94 
membrane, are trans receptors for glial membrane-associated MAG (indicated in Figure 1A)(Collins 95 
et al., 1997; Vinson et al., 2001). Analysis of protein extracts demonstrated a reduction in MAG levels 96 
in GalNAc-T-/- mice (Sheikh et al., 1999; Kawai et al., 2001), which suggests that complex neuronal 97 
gangliosides and glial MAG cooperatively contribute to the stability of the axo-glial junction.  98 
Importantly, loss of sulfatide does not alter ganglioside content (Honke et al., 2002) and complex 99 
ganglioside deficiency does not alter sulfatide content (Yamashita et al., 2005) which suggests their  100 
expression is not directly inter-linked in a compensatory way, but nevertheless might be additive 101 
functionally. Herein we considered that as these glycolipids are differentially expressed in glial and 102 
axonal membranes, they may act in partnership to retain clustered proteins in their respective 103 
domains. We sought to test this by interbreeding strains of single null mice and neuronal and glial 104 
specific rescue mice, thereby allowing us to assess interdependency and cooperativity in the role of 105 
axonal and glial glycolipids in paranodal organisation.  106 
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Methods 107 
Mice. Seven mouse lines on the C57Bl/6 background were used and generated: 1. Wild type (WT); 2. 108 
GalNAc-T-/-; 3. CST-/-; 4. CST-/- x GalNAc-T-/--Tg(neuronal); 5. CST-/- x GD3s-/-; 6. CST-/- x GalNAc-T-/-; 7. 109 
CST-/- x GalNAc-T-/--Tg(glial)(group number and age are described per experiment below). Generation 110 
of GalNAc-T-/- and CST-/- transgenic mice has previously been described (Takamiya et al., 1996; Honke 111 
et al., 2002) and were interbred to produce the CST-/- x GalNAc-T-/- genotype. Double null mice with 112 
reconstituted site-specific expression of complex gangliosides were produced by crossing the CST-/- 113 
genotype with previously described GalNAc-T-/--Tg(neuronal) or GalNAc-T-/--Tg(glial) strains (Yao et 114 
al., 2014) or GD3s-/- (Okada et al., 2002) resulting in CST-/- x GalNAc-T-/--Tg(neuronal), CST-/- x GalNAc-115 
T-/--Tg(glial) and CST-/- x GD3s-/-, respectively. CST-/- x GalNAc-T-/--Tg(glial) bred poorly and there were 116 
insufficient numbers to fully phenotype; therefore their inclusion was restricted to survival data and 117 
phenotypic analysis. Mice were maintained under a 12 hour light/dark cycle in controlled 118 
temperature and humidity with unlimited access to food and water. For each study, mice of either 119 
sex were killed by rising CO2 inhalation; all experiments using mice were performed in accordance 120 
with a licence approved and granted by the United Kingdom Home Office and conformed to 121 
University of Glasgow institutional guidelines. Experiments complied with relevant guidelines on the 122 
care and use of animals outlined in the revised Animals (Scientific Procedures) Act 1986. 123 
 124 
Phenotypic analysis of mice. Weights were obtained at P22 from wild type (n=5), GalNAc-T-/- (n=5), 125 
CST-/- (n=4), CST-/- x GalNAc-T-/--Tg(neuronal) (n=4), CST-/- x GD3s-/- (n=6) and  CST-/- x GalNAc-T-/- 126 
(n=10) mice. Data points from every animal per genotype were plotted, and the mean and S.E.M 127 
displayed. Survival plots for all genotypes were plotted over 200 days for each genotype: wild type 128 
(n=7); GalNAc-T-/- (n=10); CST-/- (n=18); CST-/- x GalNAc-T-/--Tg(neuronal) (n=6); CST-/- x GD3s-/- (n=38), 129 
CST-/- x GalNAc-T-/--Tg(glial) mice (n=12); and  CST-/- x GalNAc-T-/- (n=29). Mice were photographed 130 
when suspended by the tail to record hind-limb leg splaying (a feature of many neurodegenerative 131 
mutants), and gross brain anatomy was also recorded upon brain removal at P22. 132 
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 133 
Materials. Monoclonal antibodies used to detect complex a- or b-series gangliosides by 134 
immunofluorescent staining were generated and described previously (Bowes et al., 2002; Boffey et 135 
al., 2005). Anti-GM1 ganglioside antibody, DG2, and anti-GD1b antibody, MOG1, were used at 20 136 
μg/ml. A new monoclonal anti-sulfatide antibody, GAMEG3, derived from mice inoculated with 137 
sulfatide-bearing liposomes was used to detect sulfatide (Meehan et al., 2018).  Primary antibodies 138 
were used as follows: mouse anti-phosphorylated neurofilament-H antibody (NF-H, BioLegend; 139 
RRID:AB_2715851; 1:2000); rat anti-MBP (BioRad; RRID:AB_325004; 1:500); mouse anti-pan Nav 140 
(Sigma; RRID:AB_477552; 1:100); mouse anti-ankyrin G (ThermoFisher scientific; RRID:AB_2533145; 141 
1:100); rabbit anti-Caspr (gifted from Professor Peles, Weizmann Institute, Israel; 1:1500); rabbit 142 
anti-Kv1.1 (Alomone labs; RRID:AB_2040144; 1:200); rabbit anti-Nav1.6 (Sigma; RRID:AB_477480; 143 
1:100); rabbit anti-pan neurofascin (gifted from Professor Brophy, University of Edinburgh, UK; 144 
pNFasc 1:1000); mouse anti-MAG antibody (gifted from Professor Brophy, University of Edinburgh, 145 
UK; 1:100). Primary antibodies used in Western blots were rabbit anti-MAG 248 (gifted from Prof. N 146 
Groome, 1:10000)(Barrie et al., 2010) and rabbit anti-NF155 (gifted from Professor Brophy, 147 
University of Edinburgh, UK; 1:5000). Secondary antibodies for immunofluorescent staining were 148 
prepared in PBS plus 1% NGS: isotype-specific (IgG1, IgG3) Alexa Fluor 488- and 555-conjugated goat 149 
anti-mouse IgG antibodies (Molecular Probes; RRID:AB_141780); Alexa Fluor 488- and 555-150 
conjugated goat anti-rabbit (Molecular Probes; RRID:AB_141761) and anti-rat IgG antibodies 151 
(Molecular Probes; RRID:AB_141733). Secondary antibody for western blots was HRP-linked goat 152 
anti-rabbit (Dako, 1:10 000) prepared in 5% skimmed milk/T-TBS. 153 
 154 
Immunostaining, Image acquisition and analysis.   155 
Lipid localisation: Snap-frozen peripheral nerves were transversely sectioned at 10μm and collected 156 
onto APES-coated slides (n=3/genotype). Sections were treated with 100% EtOH for 10 min at -20qC 157 
then thoroughly washed in PBS. Antibodies prepared in PBS were applied to the sections overnight 158 
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at 4qC in the following combinations: 1) anti-ganglioside antibody DG2 or MOG1 with anti-159 
phosphorylated NF-H antibody; 2) anti-sulfatide antibody with anti-MBP antibody. Sections were PBS 160 
washed and secondary antibodies applied for 1h at R.T., PBS washed and mounted in citifluor. 161 
Representative images were captured at 40x magnification using a Zeiss AxioImager Z1 with 162 
ApoTome attachment and processed using Zeiss Zen 2 blue edition software. 163 
Nodal protein immunostaining: Sciatic nerves (SN) and optic nerves (OpN) were fixed for 30 min in 164 
4% PFA upon removal from P22 mice (n=3/4 per genotype). Subsequently nerves were 165 
cryoprotected in 30% sucrose, and either gently teased into single fibres (SN) collected on slides, or 166 
frozen in OCT mounting medium and longitudinally sectioned at 10 μm (OpN). To study nodal 167 
protein localization, teased SN were immunostained with primary antibodies for either anti- Nav1.6, 168 
anti-Kv1.1 or pNFasc, and OpN sections were immunostained with primary antibodies for 169 
combinations of anti- pNav and anti-pNFasc, or anti-Caspr and anti-AnkG. OpN sections and unfixed 170 
peripheral nerve sections were stained with anti- MAG antibody. Nerves were pre-treated with 171 
blocking solution (10% normal goat serum + 0.3% Triton X-100) for 1 h at 4qC before incubation 172 
overnight in the same solution plus primary antibody combinations at the same temperature. Triton 173 
was omitted from blocking and incubation solutions when using unfixed peripheral nerve sections. 174 
Samples were washed 3x 5 min then incubated for 2 h at room temperature in secondary antibody 175 
solution. After three further 5 min PBS washes, slides were mounted in citifluor. All nodal protein 176 
images were captured at 63x magnification, and MAG immunostained tissue at 40x magnification 177 
using a Zeiss AxioImager Z1 with ApoTome attachment and processed with Zeiss Zen 2 blue edition 178 
software. For teased sciatic nerves, 10 ROIs (capturing 1-12 NoR) were imaged and quantified per 179 
mouse for each protein. For optic nerve double-staining combinations, three 10 μm thick z-stacks 180 
(30 slices, step value 0.34 μm) were captured per mouse. Four 50 x 50 μm fields of view (FOV) per 181 
stack were analysed for either pNav channel cluster number, number of Nav channel clusters flanked 182 
by intact NFasc dimers, or intact Caspr dimers flanking AnkG, using NIH ImageJ software 183 
(RRID:SCR_003070). Clusters/dimers were included in the count if they overlaid the top and right-184 
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side borders of the FOV, and excluded when they overlaid the left-side or lower borders. For MAG 185 
staining intensity analysis, single slices were captured at set exposures from 3 slides per genotype. 186 
Graphs + S.E.M or box-and-whisker plots were used to display the spread of all data points collected 187 
from each animal then means were calculated per genotype for statistical analysis.  188 
 189 
Ultrastructure. Mice (WT n=5,  GalNAc-T-/- n=6, CST-/- n=6,  CST-/- x GalNAc-T-/--Tg(neuronal) n=6, CST-190 
/- x GD3s-/-n=6, CST-/- x GalNAc-T-/- n=5) were transcardially perfused at P25 with 5% 191 
glutaraldehyde/4% paraformaldehyde mixture before the optic nerve was removed and processed 192 
for resin embedding, as previously described (Griffiths et al., 1981). Sections were cut for both light 193 
and ultrastructural analysis. Electron micrographs from transverse sections of the optic nerve at 194 
6700x magnification, were captured on a Jeol CX-100 Electron microscope. For quantification, a 195 
minimum of 10 electron micrographs per animal were taken of randomly selected fields. All 196 
measurements were made on scanned images using NIH ImageJ software. For axon morphometry 197 
and quantification of axonal changes, all axons within or touching the top and left borders of an area 198 
of interest (AOI) were counted. The axon density and number of degenerating axons within the AOI 199 
were counted. Averaged values from every animal per genotype was plotted, and the mean and 200 
S.E.M displayed. 201 
 202 
Extracellular recordings.  203 
Perineural recordings were made from triangularis sterni nerve-muscle preparations set up as 204 
previously described (Braga et al., 1991; McGonigal et al., 2010). Recordings were made from small 205 
nerve bundles from each genotype (WT n=5,  GalNAc-T-/- n=2, CST-/- n=3,  CST-/- x GalNAc-T-/- n=2). 206 
Perineural Nav and Kv channel waveforms were collected during a paired pulse stimulation protocol. 207 
A representative graph plotting the peak Nav and Kv values as a percentage of the baseline 208 
waveforms at each interstimulus interval (ISI) was used to convey recovery of the nodal ion channel 209 
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currents. A two-way ANOVA was used to compare the difference between genotypes, and post-hoc 210 
multiple comparisons to measure differences at each ISI.  211 
Conduction velocity was measured in sciatic nerve (WT n=3,  GalNAc-T-/- n=4, CST-/- n=4,  CST-/- x 212 
GalNAc-T-/- n=5), as previously described (McGonigal et al., 2010). Optic nerves (between the eyeball 213 
and the optic chiasm) were quickly removed into oxygenated (95% O2 and 5% CO2) physiological 214 
Ringer’s solution containing (mM): NaCl, 129; KCl, 3; NaH2PO4, 1.2; CaCl2, 2.4; MgSO4, 1.3; HEPES, 215 
3; NaHCO3, 20; and glucose, 10. The nerves were mounted in a recording chamber and each end 216 
drawn into suction electrodes for electrophysiological studies (WT n=4,  GalNAc-T-/- n=4, CST-/- n=4,  217 
CST-/- x GalNAc-T-/--Tg(neuronal) n=3, CST-/- x GD3s-/-n=6, CST-/- x GalNAc-T-/- n=3). Compound action 218 
potentials were evoked by a supramaximal stimulus (Grass S88 stimulator), applied via a suction 219 
electrode at the proximal cut end, and recorded from a second suction electrode at the distal cut 220 
end. Signals were amplified (CED1902), digitized (NIDAQ-MX A/D converter, National Instruments, 221 
Austin, TX, USA) and analysed using WinWCP version 4.1.0 (J. Dempster, Strathclyde University, 222 
RRID:SCR_014713). Nerves were crushed at the end of the experiment in order to identify and 223 
exclude electrical artefacts from the analysis. Nerve conduction velocity was calculated by dividing 224 
the length of the nerve by latency (the time between the stimulation artefact and the highest peak 225 
of compound action potential). Average values from every animal per genotype were plotted, and 226 
the mean and S.E.M displayed. 227 
 228 
Western blot. Mouse brains were removed (n=4/genotype), snap frozen in liquid nitrogen, and 229 
stored at -80°C until required. Myelin preparation was conducted using a modification of the 230 
method by Norton and Poduslo (1973). Briefly, brains were homogenised in a buffer composed of 231 
0.85 M sucrose, 10 mM Hepes, pH 7.4, 2 mM DTT, and 1 mM TLCK for 20 sec using an Ultra-Turrax 232 
T8 blender (IKA-Works Inc., Wilmington, NC) set at maximum speed and 0.25 M sucrose gently 233 
layered on top of the homogenate and then centrifuged at 70,000g for 90 min at 4°C. The myelin 234 
interface was collected, hypotonically lysed in chilled dH2O and pelleted at 23,000g for 30 min at 4°C. 235 
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Following an additional two rounds of hypotonic lysis, the myelin pellet was resuspended in 10 mM 236 
Hepes, pH 7.4, containing 1x protease inhibitor cocktail (Sigma). The myelin fraction was stored at -237 
80°C until required. The protein concentration was determined using a bicinchoninic acid method 238 
employing BSA as a standard (Pierce, Thermo Scientific). SDS-PAGE/ Western blot analysis was 239 
conducted as previously described (Yool et al., 2001). In brief, 1 and 5 ug of myelin was denatured in 240 
Laemmli buffer, separated on a 4-12%  gel (Biorad), and transferred to nitrocellulose membrane 241 
(Invitrogen). The membrane was blocked with 5% skimmed milk in TBS containing 0.1% Tween-20 (T-242 
TBS) for 1hr at room temperature, then incubated in primary antibodies prepared in 5% semi-243 
skimmed milk in TBS containing 0.1% Tween-20 (T-TBS) overnight at 4°C on an orbital shaker. 244 
Following three 10 min washes in T-TBS, the immunocomplex was detected with the HRP-linked 245 
secondary antibody (Dako) and visualised using the ECL reaction as per manufacturer’s instructions 246 
(Pierce, Thermo Scientific). Densitometric analysis of the Western blots was performed using Image J 247 
software (NIH). Average values from every animal per genotype were plotted, and the mean and 248 
S.E.M displayed.  249 
 250 
Experimental design and statistical analysis. The number of independent animals are described in 251 
the Methods and Results sections and indicated in figure legends. Statistical differences among 252 
genotypes were determined by one-way or two-way ANOVA followed by a Fisher’s or Tukey’s post-253 
hoc tests using GraphPad Prism 6 software (RRID:SCR_002798). Differences were considered 254 
significant when p < 0.05.  255 
 256 
 257 
  258 
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Results 259 
Ganglioside and sulfatide expression is successfully eliminated in CST-/- x GalNAc-T-/- mice 260 
To investigate the interaction between ganglioside and sulfatide lipids on nervous system integrity, 261 
we studied six transgenic mouse lines: wild type; GalNAc-T-/-; CST-/-; CST-/- x GalNAc-T-/--Tg(neuronal); 262 
CST-/- x GD3s-/-; and CST-/- x GalNAc-T-/-. Table 1 provides an overview of the specific glycolipid 263 
expression and deficiency profiles among the mice generated for this study. We confirmed the 264 
presence of targeted gene disruption and reintroduction in these transgenic lines by PCR and 265 
screening for complex ganglioside or sulfatide expression in neural tissue by immunostaining (Figure 266 
1). An additional line, CST-/- x GalNAc-T-/--Tg(glial) was subsequently generated for comparative 267 
survival plots. The CST, GalNAc-T and GD3s genes are disrupted by an insert, which was assessed by 268 
PCR. From the gels in Figure 1B, the larger band represents successful GalNAc-T gene disruption in 269 
GalNAc-T-/-, CST-/- x GalNAc-T-/--Tg(neuronal) mice and CST-/- x GalNAc-T-/- mice, and CST disruption in 270 
CST-/-, CST-/- x GalNAc-T-/--Tg(neuronal) mice, CST-/- x GD3s-/-  and CST-/- x GalNAc-T-/- mice. The smaller 271 
band confirms GD3 synthase (GD3s) gene disruption in CST-/- x GD3s-/- mice. Additionally, a band 272 
identifying the GalNAc-T-flag in the CST-/- x GalNAc-T-/--Tg(neuronal) mouse strain confirms selective 273 
GalNAc-T gene re-expression neuronally. Confirmation of absence or selective expression of lipids 274 
was assessed in all genotypes with two anti-ganglioside antibodies that detected either the a- or b-275 
series complex gangliosides, and an anti-sulfatide antibody. Qualitative results for immunostaining 276 
with these antibodies in the peripheral nerve are shown in Figure 1C. As expected, neural tissue 277 
from all genotypes except GalNAc-T-/- mice and CST-/- x GalNAc-T-/- mice was positive for anti-GM1 278 
(a-series) antibody immunolabeling. Additionally, anti-GD1b antibody (b-series) binding was 279 
undetectable in GalNAc-T-/- mice and CST-/- x GalNAc-T-/- genotypes confirming absence of all a- and 280 
b-series gangliosides. Similarly, nerves from CST-/- x GD3s-/- mice, null for b-series ganglioside 281 
expression, had no observable immunolabelling with the anti-GD1b antibody. Both a- and b-series 282 
gangliosides were successfully reintroduced in the axons of the CST-/- x GalNAc-T-/--Tg(neuronal) 283 
mouse line as shown by positive anti-GM1 and anti-GD1b immunoreactivity. When neural tissue was 284 
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immunostained with anti-sulfatide antibody, positively labelled myelin was observed in wild type 285 
and GalNAc-T-/- mice nerves, while no labelling was detected in the other four genotypes, confirming 286 
the absence of sulfatide expression with CST gene knock out.  287 
 288 
Ganglioside and sulfatide double null mice have a significantly reduced lifespan 289 
The complex ganglioside null and sulfatide null mouse strains have an age-dependent degenerative 290 
phenotype that manifest clinically from 4 months and 6 weeks respectively. In contrast to each of 291 
the single glycolipid deficient mice, the CST-/- x GalNAc-T-/- mice exhibited a very severe phenotype 292 
from 2 weeks, lethal by 4 weeks. The mice appear to develop normally and are similar in size to wild 293 
type and single knock out mice, then subsequently fail to thrive, declining in body weight beyond 294 
P15 and showing a significant reduction in weight at P22 (one-way ANOVA F(5,28) = 18.15, 295 
p<0.0001)(Figure 2A). Single pup rearing through removal of litter-mates on three occasions did not 296 
prolong survival. CST-/- x GalNAc-T-/- mice exhibit a hunched, emaciated appearance, develop a 297 
tremor and display hind-limb leg splaying (Figure 2B), a typical characteristic of the single knock out 298 
mice at later stages of life. Despite reduction in weight, macroscopic  brain (Figure 2B) and nerve 299 
anatomy appear comparable to other genotypes. Survival plots demonstrate that incrementally 300 
diminishing ganglioside and sulfatide expression corresponds with a reduction in life expectancy, 301 
measured up to 200 days (Figure 2C).Wild type and GalNAc-T-/- mice have a normal life expectancy 302 
up to 200 days. CST-/- x GalNAc-T-/- mice have the shortest life expectancy of the lines studied, never 303 
surviving beyond 4 weeks, with the majority only surviving to P21-P25. In the absence of sulfatide 304 
expression, but with normal ganglioside expression, CST-/- life expectancy at 200 days more than 305 
halves. In mice lacking sulfatide and complex gangliosides globally but with all complex gangliosides 306 
reintroduced specifically into neurons (i.e. the CST-/- x GalNAc-T-/--Tg(neuronal) mouse), life 307 
expectancy is restored to that of sulfatide null mice, with 60% of mice surviving to at least 200 days. 308 
Additionally, weight at P22 is comparable in this genotype to WT, CST-/- and GalNAc-T-/- mice (Figure 309 
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2A). In order to determine whether a- or b-series complex ganglioside deficiency was responsible for 310 
the severity of the double sulfatide and complex ganglioside null mouse, we examined mice that 311 
expressed a-series gangliosides only and lacked b-series gangliosides (achieved through crossing 312 
sulfatide and b-series null mice). These were only modestly improved relative to the CST-/- x GalNAc-313 
T-/- phenotype, as shown by the failure to thrive and significant weight loss at P22 (Figure 2A). Life 314 
expectancy is severely reduced with only 50% survival at 4 weeks, and less than 10% mice reaching a 315 
maximum of 21 weeks (Figure 2C).  To determine the importance of neuronal relative to glial 316 
ganglioside expression, CST-/- x GalNAc-T-/- mice were generated with glial expression of complex 317 
gangliosides, i.e.  CST-/- x GalNAc-T-/--Tg(glial). Unlike the successful rescue of the lethal phenotype 318 
with neuronal complex gangliosides, expression of complex gangliosides in glial membranes did not 319 
improve CST-/- x GalNAc-T-/- survival. Therefore based on survival data, the genotypes can be 320 
categorised into three subsets: mild (WT, GalNAc-T-/-); moderate (CST-/-, CST-/- x GalNAc-T-/--321 
Tg(neuronal); and severe (CST-/- x GD3s-/-, CST-/- x GalNAc-T-/-) (Figure 2C).  322 
 323 
Loss of both sulfatide and complex gangliosides results in a disruption to CNS nodes of Ranvier  324 
Age-dependent loss of nodal integrity is evident in both single ganglioside and sulfatide null mice 325 
and could potentially contribute to loss of normal ion channel clustering, functional deficits and axon 326 
degeneration. Of the single lipid deficient mice, disrupted nodal integrity is more rapid and 327 
pronounced in the sulfatide null mice, beginning post-myelin development (>1 month). To assess 328 
whether this process was enhanced or accelerated in CST-/- x GalNAc-T-/- mice, we initially assessed 329 
changes in both the PNS (sciatic nerve, internal intercostal nerve) and the CNS (optic nerve, brain) at 330 
P22. When the PNS integrity was examined, we found that there was no change in number of nodes 331 
per ROI among genotypes (one-way ANOVA, F(3,9)=0.1261, p=0.94; WT= 4.07 + 1.09; GalNAc-T-/- = 332 
4.27 + 0.97; CST-/- = 3.9 + 0.15; CST-/- x GalNAc-T-/- = 4.5 + 0.58), and therefore focused on 333 
characterising changes to nodal protein immunostaining. In general, combined sulfatide and 334 
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complex ganglioside deficiency did not augment the disorganisation of proteins at the node of 335 
Ranvier of the single sulfatide null mice (Figure 3A). Peripheral nerve Nav channel cluster domains 336 
were lengthened both in CST-/- and CST-/- x GalNAc-T-/- sciatic nerves. Despite results reaching 337 
significance (one-way ANOVA, F(3,9)=0.5794, p=0.0491), post-hoc multiple comparisons showed the 338 
Nav channel cluster domain length in the latter genotypes did not reach significance compared to 339 
WT, GalNAc-T-/- or each other. In both CST-/- and CST-/- x GalNAc-T-/- sciatic nerve nodes of Ranvier 340 
immunostaining for Kv1.1 channel domains, normally located at the juxtaparanodes, invaded the 341 
paranodal region, shown by a shortening in the distance between the staining domains, compared to 342 
WT and GalNAc-T-/- nerves (one-way ANOVA, F(3,9), p<0.0001). This indicated impairment to 343 
paranodal organisation. Despite the fact that pNFasc staining length did not significantly change 344 
among genotypes (one-way ANOVA, F(3,9) = 1.157, p= 0.38), the overall appearance of the staining 345 
pattern did differ. WT and GalNAc-T-/- nodes of Ranvier have pNFasc staining that is most intense at 346 
the paranodes forming two clear dimers (normal), while both the CST-/- and CST-/- x GalNAc-T-/- 347 
mice have intense staining at the nodal gap (the NF186 component) with weaker paranodal (the 348 
NF155 component) staining (abnormal). By undertaking qualitative assessment of these “normal” 349 
and “abnormal” staining patterns, we found WT and GalNAc-T-/- mice had significantly more normal 350 
pNFasc immunostaining than CST-/- and CST-/- x GalNAc-T-/- mice, which were similar to each other 351 
(two-way ANOVA, F(3,18)=9.56, p=0.0063; WT= 88% ¬+ 2.8; GalNAc-T-/- = 75.67% + 4.5; CST-/- = 352 
29.67% + 3.2; CST-/- x GalNAc-T-/- = 35% + 10.2). These results, taking alongside the evident  Kv1.1 353 
invasion of the paranodal region, indicates a disturbance in paranodal organisation. Additionally, 354 
electrophysiological function did not significantly worsen in CST-/- x GalNAc-T-/- peripheral nerve 355 
compared to single sulfatide deficient nerve based on paired pulse stimulations and conduction 356 
velocity measurements (Figure 3B). We performed perineural recordings to assess the Nav and Kv 357 
channel currents of the internal intercostal nerve that innervates the TS muscle. The recovery of 358 
both peaks after paired pulse stimulation was significantly different among genotypes (Nav peak: 359 
two-way ANOVA, F(3,117) = 10.79, p<0.0001. Kv peak: two-way ANOVA, F(3,117) = 32.24, p<0.0001). 360 
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Both CST-/- and CST-/- x GalNAc-T-/- peaks were significantly reduced in the initial interstimulus 361 
intervals compared to WT and GalNAc-T-/- preparations, but did not differ from one another, as 362 
indicated on the graphs in Figure 3B. Conduction velocity was slower in GalNAc-T-/-, CST-/- and CST-/- x 363 
GalNAc-T-/- sciatic nerve compared to WT, but only reached significance in CST-/- nerve (one-way 364 
ANOVA, F(3,12) = 3.939, p = 0.036). MAG immunostaining was comparable in peripheral nerves of all 365 
four genotypes (Figure 3C). It is thus unlikely that PNS dysfunction and degeneration would account 366 
for the lethal phenotype in double deficient mice and there was no evidence of further disruption to 367 
the PNS in the double deficient mice compared to the sulfatide null mice. As such, we then focussed 368 
our attention on the CNS with additional Tg lines. When comparing Nav channel clustering in the 369 
optic nerve from all genotypes there is a significant reduction in Nav channel cluster number (one-370 
way ANOVA (F(5,13) = 4.76, p=0.0108). CST-/- x GalNAc-T-/- mice have fewer Nav channel clusters 371 
than all other genotypes, but this reduction only reached significance when compared to wild type 372 
and complex ganglioside deficient mice, which were not significantly different to each other (Figure 373 
4A). Although reduced, the number of Nav channel clusters is within the normal wild type range 374 
when sulfatide is expressed or complex gangliosides are reintroduced in the neuronal membrane in 375 
CST-/- x GalNAc-T-/--Tg(neuronal) mice. This is not the case when a-series gangliosides are expressed 376 
globally on the sulfatide null background in CST-/- x GD3s-/- mice, which have similar cluster numbers 377 
to CST-/- x GalNAc-T-/- mice. Since cluster number does not explicitly define mature nodes of Ranvier, 378 
the number of Nav channel clusters flanked laterally by intact paranodal neurofascin dimers were 379 
assessed. Earlier reports have shown that lack of sulfatide attenuates neurofascin 155 localisation to 380 
the paranodal region (Ishibashi et al., 2002; Schafer et al., 2004; Marcus et al., 2006), and indeed we 381 
found all four lines with sulfatide deficiency had significantly fewer neurofascin positive paranodal 382 
dimers flanking Nav channel clusters as early as P22 compared to wild type and GalNAc-T-/- mice 383 
(one-way ANOVA (F5,13) = 21.31, p<0.0001)(Figure 4B,C). A pan-neurofascin antibody was used that 384 
detects both the neuronal NF186 and glial NF155 isoforms critical for Nav channel clustering and 385 
paranodal axo-glial junction formation, respectively. We detected no change to presumed nodal 386 
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NF186 presence and observed normal co-localisation with Nav channel clusters suggesting this 387 
isoform is not impacted by ganglioside or sulfatide lipid expression. Further analysis showed 388 
paranodal Caspr dimers flanking Ankyrin G were significantly reduced at P22 in all genotypes, with 389 
the exception of GalNAc-T-/- mice, compared to wild type mice (one-way ANOVA (F(5,14) = 8.8, 390 
p=0.0006) (Figure 5). However, significance was greatest when wild type was compared to GalNAc-T-391 
/- x CST-/- and CST-/- x GD3s-/- mice. GalNAc-T-/- x CST-/- mice also showed a significant reduction 392 
compared to CST-/- and CST-/- x GalNAc-T-/--Tg(neuronal) nerves. Expression of neuronal a- and b-393 
series gangliosides improved the feature under examination, but global a-series ganglioside 394 
expression did not. Our results show a more exaggerated loss in paranodal neurofascin than Caspr, 395 
as judged by immunostaining. We attribute this finding to normal localisation during early 396 
development, with subsequent loss of NF155 followed by Caspr as the maturing node begins to 397 
deteriorate over time. However, it is also possible that the pNFasc antibody is not as sensitive as the 398 
Caspr antibody, accounting for apparent relative quantitative differences.  399 
 400 
Glycolipid deficiency compromises CNS axon integrity and function 401 
Age-dependent degeneration beyond 2 months of age is a feature of the CST-/- and the GalNAc-T-/- 402 
mouse strains. The principal ultrastructural abnormality observed in the current study was early 403 
onset CNS axon degeneration in the CST-/- x GalNAc-T-/- mice characterised by axons with dark 404 
condensed cytoplasm, organelle or vacuole filled axons or empty myelin sheaths with or without 405 
axonal fragments. We have indicated the various abnormalities observed in OpN from CST-/- x 406 
GalNAc-T-/- mice in a representative image (Figure 6A). Electron micrographs indicate degenerating 407 
axons (arrowheads) and show the normal formation of myelin in large diameter myelinated fibres, 408 
alongside abundant unmyelinated and thinly myelinated fibres undergoing myelin maturation in all 409 
genotypes (Figure 6B). There was a significant increase in degenerating axons in the optic nerve at 410 
P25 with diminishing glycolipid expression (one-way ANOVA (F(5,29) = 9.408, p<0.0001).  CST-/- x 411 
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GalNAc-T-/- mice had significantly more degenerating axons compared to wild type and GalNAc-T-/- 412 
nerves, which are comparable (Figure 6C). The number of degenerating axons in CST-/- mice was very 413 
variable and reached significance compared to wild type. Additionally, the number of degenerating 414 
axons in CST-/- mice  were fewer than observed for CST-/- x GalNAc-T-/- optic nerve but this difference 415 
did not reach significance. A protection of axons from degeneration was achieved by reinstatement 416 
of both a- and b-series gangliosides neuronally, leading to a reduction in the number of degenerating 417 
axons to within wild type and GalNAc-T-/- levels. However, the number of degenerating axons was 418 
not improved by expression of global a-series ganglioside expression in the CST-/- x GD3s-/- strain, 419 
which were equal to CST-/- x GalNAc-T-/- levels. To investigate the functional consequence of 420 
degenerating axons and nodal structure disturbance, conduction velocity was recorded from 421 
isolated optic nerve at P22 (Figure 6D). Conduction velocity was significantly reduced with 422 
diminishing glycolipid expression (one-way ANOVA F(5,18) = 4.25, p= 0.01), which correlated with 423 
the survival plots, nodal and ultrastructural data. The reduction in CV did not reach significance 424 
between any of the genotypes in post-hoc analysis.  425 
 426 
MAG protein expression in myelin is disrupted in sulfatide and ganglioside double null mice 427 
Sulfatide deficiency has previously been reported to alter expression of key myelin proteins, 428 
prompting us to interrogate differences in the expression of these proteins in the 6 genotypes 429 
studied. Expression of the major myelin proteins PLP and MBP in the myelin fraction from P22 brain 430 
homogenates did not significantly differ among the six genotypes, with the exception of a mildly 431 
reduced expression in WT mice compared to GalNAc-T-/- genotypes (data not shown). A significant 432 
reduction in MAG protein level was observed in the myelin fraction from CST-/- x GalNAc-T-/- mice 433 
compared to all genotypes, which did not significantly differ from one another (one-way ANOVA 434 
F(5,16) = 7.735, p=0.0007) (Figure 7A). Conversely, MAG expression in whole brain homogenates and 435 
in optic nerve sections was comparably reduced in all genotypes compared to wild type, suggesting 436 
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an enhanced loss of appropriate trafficking or site-specific anchoring in myelin in the CST-/- x GalNAc-437 
T-/- mice (WB: one-way ANOVA F(5,18) = 13.87, p<0.0001; immunostaining one-way ANOVA F(5,12) = 438 
13.36, p = 0.0001) (Figure 7A & B). This notion is strengthened by the comparable expression of 439 
oligodendrocyte transcription factor 2 (Olig2) among genotypes which indicates oligodendrocyte 440 
number is normal and oligodendrocytes are not lost due to glycolipid deficiency (one-way ANOVA 441 
F(5,12) = 0.41, p = 0.835)(Figure 7A). Myelin NF155 protein levels were significantly reduced to a 442 
comparable level in all genotypes deficient in sulfatide, which corresponds with our immunostaining 443 
data and previous reports (one-way ANOVA F(5,18) = 23.41, p<0.0001) (Figure 7A). This is replicated 444 
in the whole brain extract (data not shown).   445 
  446 
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Discussion  447 
Glycosphingolipids including sulfatide and complex gangliosides have a significant role in myelinated 448 
nerve maintenance, but their distinct or interdependent roles and interactions are unclear. The 449 
neurodegenerative consequence of deficiency in either sulfatides or complex ganglioside synthesis 450 
through transgenic manipulation indicates a role for these lipids in maintaining myelin and axonal 451 
integrity, particularly at the node of Ranvier (Takamiya et al., 1996; Sheikh et al., 1999; Honke et al., 452 
2002; Ishibashi et al., 2002; Marcus et al., 2002; Hoshi et al., 2007; Susuki et al., 2007). It was the aim 453 
of this study to investigate their interdependency on interacting membranes in order to add insight 454 
to the role each family of lipids plays in myelinated nerve and nodal stability.  455 
We found that interbreeding sulfatide deficient mice with complex ganglioside deficient mice 456 
resulted in an exaggerated neurodegenerative phenotype and early death compared to single null 457 
mice. Through a combination of ultrastructural, immunohistological, functional, and biochemical 458 
studies, we showed that the combined loss of both groups of lipids resulted in a more severe 459 
outcome than single lipid deficiency (Takamiya et al., 1996; Honke et al., 2002). Diminishing 460 
expression of lipids divided the survival of the seven genotypes produced for this study into three 461 
broad groups: Mild (WT and GalNAc-T-/-); Intermediate (CST-/-, CST-/- x GalNAc-T-/--Tg(neuronal)); 462 
Severe (CST-/- x GD3s-/-, CST-/- x GalNAc-T-/--Tg(glial), CST-/- x GalNAc-T-/-). We reported a more 463 
pronounced phenotype in the CNS than the PNS and thereby focused much of our analysis on the 464 
CNS. Degenerating axon number increased with diminishing lipid content and conduction became 465 
increasingly impaired; MAG expression in the myelin fraction from brain homogenates was 466 
significantly lower in the CST-/- x GalNAc-T-/- genotype compared to all other genotypes; and Nav 467 
channel cluster number, Caspr dimer number and Nav channels flanked by NF155 dimers decreased 468 
with decreasing lipid expression. Rescuing the neuronal, but not the glial complex ganglioside 469 
expression reversed the lethality observed in the double null mice. Examining the relative 470 
importance of a- and b-series gangliosides we observed only modest improvement occurred with 471 
global a-series ganglioside expression on a sulfatide null background. Collectively, these data 472 
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indicate the importance of neuronal b-series gangliosides (e.g. GD1b, GT1b) in maintaining survival in 473 
the co-presence of sulfatide deficiency and indicate interdependency between the functions of these 474 
two groups of lipids. We thus propose that sulfatide and b-series ganglioside lipid domains on 475 
opposing membranes majorly contribute to a co-ordinated axo-glial adhesion and paranodal 476 
organisation, a combined loss of which leads to severe impairment of nerve integrity with a fatal 477 
outcome at an early age.  478 
We have previously highlighted the significance of neuronal complex ganglioside expression to nerve 479 
integrity in the GalNAc-T-/- age-dependent neurodegenerative genotype (Yao et al., 2014). 480 
Considering the impact of neuronal ganglioside expression on survival, combined with the reduction 481 
of MAG in the myelin fraction in double deficient mice, these findings suggest an underlying 482 
mechanism for the lethal phenotype in CST-/- x GalNAc-T-/- mice. The complex gangliosides GD1a and 483 
GT1b are prominently expressed on the axonal membrane and are receptors for MAG (Collins et al., 484 
1997; Vinson et al., 2001). MAG is expressed on the periaxonal membrane of the myelin sheath 485 
(Bartsch et al., 1989; Trapp et al., 1989) and is involved in the continuous axo-glial contact and 486 
bidirectional signalling along the myelinated nerve, particularly at the paranode. MAG forms cis 487 
bonds in the myelin membrane that are stabilised by trans interactions with gangliosides in the 488 
neuronal membrane (Pronker et al., 2016). MAG null mice exhibit delayed maturation of nodes and, 489 
similar to GalNAc-T-/- mice, modest nervous system abnormalities, suggesting a role in myelinated 490 
nerve maintenance rather than development (Montag et al., 1994; Li et al., 1998; Marcus et al., 491 
2002; Pan et al., 2005). Previously it has been shown that MAG levels are reduced in GalNAc-T-/- mice 492 
(Sheikh et al., 1999; Kawai et al., 2001), and suggests, when considered with the comparable 493 
phenotype between GalNAc-T-/- and MAG-/- mice, complex gangliosides and MAG cooperatively 494 
contribute to the stability of the axo-glial junction. Indeed, interbreeding GalNAc-T-/- and MAG-/- 495 
strains did not exacerbate the phenotype of the single null mice, suggesting a complementary and 496 
functional interaction between these molecules (Pan et al., 2005). Conversely, in our study, 497 
combining GalNAc-T-/- and CST-/- strains exacerbates the phenotype suggesting two independent 498 
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roles. Notably, MAG acts as a myelin receptor for axonal gangliosides, and could be localised to the 499 
myelin membrane by sulfatide rich lipid rafts.  Recent analysis of protein extracts from 4-week old 500 
sulfatide null mouse brains confirmed a progressive reduction in MAG and a significant reduction in 501 
NF155 (25% compared to wild type)(Palavicini et al., 2016). Taken together with extraction studies 502 
that suggested sulfatide-containing lipid rafts could be anchors for MAG and NF155 (Pomicter et al., 503 
2013), it seems that sulfatide may act as a wide-ranging anchor for multiple myelin and glial 504 
membrane proteins. With the knowledge that MAG and sulfatide modulate axo-glial stability, 505 
Marcus et al. (2002) investigated the significance of both molecules to axo-glial integrity by crossing 506 
MAG deficient mice with GalC/sulfatide double-deficient mice, which individually have similar 507 
phenotypes. Similar to our lethal sulfatide and ganglioside double deficiency phenotype, this genetic 508 
combination resulted in a lethal phenotype, with survival up to P22 (Marcus et al., 2002). Again, the 509 
NoR appear to develop normally followed by subsequent generalised impairment of the paranodal 510 
axo-glial junction. Unlike the minimal effect of combined MAG and complex ganglioside disruption, 511 
MAG and ceramide galactosyltransferase (CGT) double deficiency aggravates the phenotype 512 
suggesting two non-redundant functions are impaired. This phenotype corresponds temporally to 513 
our lethal phenotype, indicating that a loss of interaction between MAG and gangliosides in a 514 
membrane environment devoid of GalC and sulfatide is fatal. It is likely that GalC/sulfatide has a role 515 
in promoting localisation/anchoring of MAG and subsequently MAG/ganglioside promote axo-glial 516 
integrity. Indeed, we reported a striking deficiency in MAG in the myelin fraction of our double null 517 
mice compared to all other genotypes owing to the loss of its glial membrane localising agent, 518 
sulfatide, and binding partner, complex gangliosides. 519 
The severe neurodegenerative phenotype of our double lipid deficient mice reflected that of 520 
paranodal protein deficient mice (Tait et al., 2000; Bhat et al., 2001; Boyle et al., 2001; Charles et al., 521 
2002). In the current study we restricted our investigation of nodal disruption to those proteins 522 
related to function (Nav and Kv channels) or previously identified as lipid raft associated (NF155, 523 
Caspr)(Sheikh et al., 1999; Schafer et al., 2004; Susuki et al., 2007; Pomicter et al., 2013) and 524 
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acknowledge that this was not an exhaustive study. Adhesion molecules freely diffuse in the axon 525 
membrane and accumulate at NoR, whereas ion channels and components of the cytoskeleton 526 
require transport (Zhang et al., 2012). NF186 is essential for maintenance of the Nav channel clusters 527 
at the NoR (Zhang et al., 2012; Desmazieres et al., 2014; Taylor et al., 2017) and appeared 528 
unperturbed in our double null mice. This aligns with the fact that NF186 is likely not raft-associated 529 
(Schafer et al., 2004; Susuki et al., 2007). The presence of NF186 accounts for the relatively minimal 530 
reduction in Na channel clusters and impairment in conduction observed in CST-/- x GalNAc-T-/- mice. 531 
Schafer et al. (2004) proposed an indirect mechanism of axo-glial junction stabilisation at the 532 
paranode whereby glycosphingolipid-rich lipid rafts cluster NF155 that then co-cluster with axonal 533 
binding partners Caspr and contactin. Indeed, we confirmed by immunostaining and western blot 534 
that NF155 was disrupted in all genotypes with sulfatide deficiency. The axonal partner of NF155, 535 
Caspr, was also disrupted as had previously been shown in single ganglioside and sulfatide deficiency 536 
(Ishibashi et al., 2002; Susuki et al., 2007), but to a greater degree when both sets of lipids were 537 
absent. Caspr has been associated with ganglioside-rich lipid rafts on the axonal membrane and in 538 
their absence, Caspr is not anchored (Susuki et al., 2007). Our results that the PNS was less 539 
perturbed than CNS likely reflects the greater stability of the peripheral node of Ranvier, and greater 540 
influence that the paranode has on stability in the CNS (Rasband and Peles, 2015). However, the 541 
combined absence of both NF155 and Caspr through loss of both sulfatide and gangliosides, 542 
respectively, likely intensifies the reduction in Nav channel clusters and ultimately leads to enhanced 543 
nodal instability compared to single lipid null mice.  544 
Ganglioside, sulfatide and MAG single deficient mice do not exhibit a severe phenotype, strongly 545 
suggesting redundant functions: overexpression/loss of other lipids (e.g. simple gangliosides, 546 
seminolipid) could, in theory, contribute to the overall phenotype in transgenic mice. Mice that lack 547 
the GD3 synthase (GD3s) enzyme that underlies production of all b-series gangliosides (Figure 1A) 548 
have grossly normal nodal architecture (Okada et al., 2002), demonstrating that there is 549 
compensation in the ganglioside family. It is possible that ganglioside deficient mice have a less 550 
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severe phenotype than those lacking sulfatide due to compensation by over-expression of simple 551 
gangliosides, notably GM3 & GD3 whose levels are markedly elevated in the GalNAc-T-/- phenotype 552 
(Susuki et al., 2007). The increased severity of double ganglioside null (GM3 only) mice (Kawai et al., 553 
2001; Inoue et al., 2002; Yamashita et al., 2005) lends support to this idea, however, the nodal 554 
protein organisation has not been characterised. It was therefore an unexpected finding that the 555 
CST-/- x GD3s-/- strain had such a severe phenotype. This could be thus explained by the lack of the b-556 
series ganglioside GT1b interacting with MAG, although these mice express large amounts of GD1a, 557 
another axonally localised MAG binding ganglioside (Vinson et al., 2001).  558 
It is clear from these results that sulfatide and complex gangliosides have crucial and independent 559 
roles in clustering proteins on opposing membranes which is essential to normal axo-glial integrity 560 
and nervous system function, as proposed in Figure 8. Redundant features can compensate for the 561 
loss of one family, but their simultaneous absence leads to a catastrophic axon degeneration, axo-562 
glial disruption and nodal pathology, culminating in early death.    563 
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Table 1. A comparison of lipid and enzyme expression profiles among the mouse genotypes used in 731
this study.  732
 30 
 
 733 
 734 
Figure 1. Generation of lipid deficient transgenic mouse lines and confirmation by PCR and 735 
immunostaining. Six mouse lines were used and generated: Wild type; GalNAc-T-/-; CST-/-, CST-/- x 736 
GalNAc-T-/--Tg(neuronal); CST-/- x GD3s-/-; CST-/- x GalNAc-T-/-. A) Sulfatide and ganglioside 737 
biosynthesis pathways (associated gene knock outs are indicated in boxes). Ceramide is the 738 
precursor to sulfatide and gangliosides. The cerebroside sulfotransferase (CST) enzyme is necessary 739 
for the synthesis of sulfatide from galactocerebroside (GalC). The GalNAc-transferase (GalNAc-T) 740 
enzyme is necessary for generation of complex gangliosides and the GD3 synthase (GD3s) enzyme 741 
for specific production of a-series complex ganglioside. Constructs were generated to drive GalNAc-T 742 
expression in neurons of GalNAc-T-/- x CST-/- mice to produce the GalNAc-T-/--Tg(neuronal) mouse 743 
line.  Location of MAG binding site to terminal 2,3 sialic acid is indicated by a red circle. B) PCR 744 
 31 
 
results confirm presence or absence of GalNAc-T, GD3s and CST expression in mouse lines. Large 745 
bands represent the disrupted GalNAc-T and CST gene with insert, while the smaller band represents 746 
the disruption of the GD3s gene. The flag identifies the re-introduction of the GalNAc-T gene into the 747 
neurons. C) Expression of a- and b- series gangliosides and sulfatide was confirmed by staining 748 
peripheral nerves with anti-GM1, anti-GD1b and anti-sulfatide monoclonal antibodies (green), 749 
respectively. Axons and myelin were identified with neurofilament or MBP (red), respectively. Scale 750 
bar = 10 μm.751 
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 752 
 753 
Figure 2. Altering the expression of gangliosides and sulfatide in novel transgenic mouse lines effects 754 
survival and phenotype. A) The weight of double null (n=10) and CST-/- x GD3s-/- (n=6) mice is normal 755 
during development, but declines from P15-25 and is significantly reduced compared to other 756 
genotypes at P22. Statistical differences among genotypes were determined by one-way ANOVA 757 
followed by Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as 758 
follows: *p<0.05; **p<0.01; ***p<0.001. B) CST-/- x GalNAc-T-/- and CST-/- x GD3s-/- mice display a 759 
reduction in stature, hindlimb leg splaying, a hunched appearance and tremor at P22. Gross brain 760 
anatomy does not differ between genotypes. C) Survival plots demonstrate that incrementally 761 
diminishing ganglioside and sulfatide expression corresponds with a reduction in life expectancy up 762 
to 200 days. Wild type (n=7) and GalNAc-T-/- (n=10) mice have a normal life expectancy. In the 763 
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absence of sulfatide with normal ganglioside expression life expectancy is more than halved in CST-/- 764 
mice (n=18). Interestingly, in the absence of sulfatide and complex gangliosides with the 765 
reintroduction of complex gangliosides into neurons alone (n=6), life expectancy is improved with 766 
60% of mice surviving to 200 days and beyond. Mice with no sulfatide and a-series gangliosides 767 
expressed globally (n=38) can survive up to 20 weeks. Double ganglioside and sulfatide knock out 768 
mice (n=29) have the worst phenotype, never surviving past 4 weeks and with death occurring at 769 
P21-25. Reintroduction of gangliosides into glial (n=12) does not improve survival.    770 
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 771 
Figure 3. The additional loss of complex gangliosides on a sulfatide null background does not 772 
augment disorganisation at the node of Ranvier or electrophysiological function in the peripheral 773 
nervous system. A) There is modest Nav1.6 channel cluster domain lengthening in both CST-/- and 774 
CST-/- x GalNAc-T-/- teased sciatic nerve that does not reach significance. Representative images from 775 
teased sciatic nerves immunostained for Nav1.6 show Nav channel cluster appearance was similar in 776 
every genotype.  Disturbance of the paranode is indicated by invasion of Kv1.1 channels into the 777 
paranode, shown by a decrease in the gap between positive domains. The gap between Kv1.1 778 
positive domains is significantly and comparably decreased in both CST-/- and CST-/- x GalNAc-T-/- mice 779 
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compared to WT and GalNAc-T-/- nodes of Ranvier. Representative images show that Kv1.1 formed 780 
two distinct domains of immunostaining at the juxtaparanodes in WT and GalNAcT-/- mice. 781 
Conversely, mice lacking sulfatide expression had Kv1.1 staining at the paranodes, suggesting 782 
disruption to the axo-glial junction. The length of pan-neurofascin (pNFasc) immunostained domains 783 
does not significantly differ among genotypes. However, representative images show that labelling 784 
greatly differs: WT and GalNAc-T-/-  nodes of Ranvier have pNFasc staining that is most intense at the 785 
paranodes forming two clear dimers (“normal”), while both the CST-/- and CST-/- x GalNAc-T-/- mice 786 
have intense staining at the nodal gap (presumed NF186) with weaker paranodal (presumed NF155) 787 
staining (“abnormal”), which indicates a disturbance in paranodal adhesion (WT n=3,  GalNAc-T-/- 788 
n=3, CST-/- n=3,  CST-/- x GalNAc-T-/- n=4). Scale bar = 5 μm. B) Perineural recordings of Nav and Kv 789 
channel currents from intercostal nerves showed an increase in recovery time for both peaks 790 
following paired pulse stimulation in both CST-/- and CST-/- x GalNAc-T-/- mice compared to WT and 791 
GalNAc-T-/- mice. The CST-/- and CST-/- x GalNAc-T-/- mice were not significantly different from each 792 
other at any interstimulus interval. Graphs display the means and +SEM for each genotype (WT n=5,  793 
GalNAc-T-/- n=2, CST-/- n=3,  CST-/- x GalNAc-T-/- n=2), and statistical analysis performed (two-way 794 
ANOVA; # signifies WT vs. CST-/- x GalNAc-T-/- mice; * signifies WT vs CST-/-; + signifies GalNAc-T-/- vs 795 
CST-/- x GalNAc-T-/-; ^ signifies GalNAc-T-/- vs CST-/- x GalNAc-T-/-). Sciatic nerve conduction velocity 796 
decreased in CST-/-(n=4), GalNAc-T-/- (n=4) and CST-/- x GalNAc-T-/- (n=5) mice compared to wild type 797 
(n=3), but only reached significance in CST-/- nerve. C) Peripheral nerve MAG immunostaining was 798 
comparable among genotypes. Scale bar = 20 μm. Graphs display the means and +SEM for each 799 
genotype, and statistical analysis performed (one-way ANOVA followed by Tukey’s post-hoc tests to 800 
compare multiple comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; ***p<0.001. 801 
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 802 
Figure 4. Loss of both sulfatide and complex gangliosides results in a modest reduction in CNS Nav 803 
channel cluster number and sulfatide deficiency reduces NF155 presence at parnodal loops. A) The 804 
number of Nav channel clusters significantly decreases in glycolipid deficient mouse optic nerves 805 
(n=3-4/genotype). Reintroducing a- and b-series gangliosides into neurons rescues this feature. B) 806 
Nav channel clusters flanked by normal paranodal neurofascin dimers are significantly reduced in 807 
number when sulfatide is not expressed (n=2-3/genotype). Box-and whisker plots are used to display 808 
the spread of all data points collected from each animal then means were calculated per genotype 809 
for statistical analysis (one-way ANOVA followed by Tukey’s post-hoc tests to compare multiple 810 
comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; ***p<0.001). C) Representative 811 
images of optic nerve sections from each genotype double-immunostained for pan-voltage gated 812 
sodium channel (pNav) antibody (green) and pan-neurofascin (pNFasc) antibody (red). Na channel 813 
clusters were observed in every genotype. pNFasc immunostaining formed a long band crossing the 814 
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node and paranodes in WT and GalNAc-T-/- mice suggesting labelling of the NF186 and NF155 815 
isoforms, respectively. All of the genotypes lacking sulfatide expression had pNFasc staining 816 
restricted to the node of Ranvier and co-localising only with pNav staining, suggesting presence of 817 
only the NF186 isoform of neurofascin. Scale bar = 5 μm.  818 
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 819 
Figure 5. Paranodal Caspr dimer immunostaining in CNS tissue is progressively reduced with 820 
increasing glycolipid deficiency. A) CST-/- x GalNAc-T-/- and CST-/- x GD3s-/- mice have significantly 821 
fewer Caspr dimers per field of view (FOV) compared to WT and GalNAc-T-/- mice, and are not 822 
significantly different to each other (n=2-5/genotype). Caspr dimer number is improved to levels 823 
within GalNAc-T-/- mice range, but not WT, in CST-/- and CST-/- x GalNAc-T-/--Tg(neuronal) mice, which 824 
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both display significantly more Caspr dimers than CST-/- x GalNAc-T-/-  mice. Box-and whisker plots 825 
are used to display the spread of all data points collected from each animal then means were 826 
calculated per genotype for statistical analysis (one-way ANOVA followed by Tukey’s post-hoc tests 827 
to compare multiple comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; 828 
***p<0.001).  B) Representative images of optic nerve sections from each genotype double-829 
immunostained for Caspr (red) and nodal marker AnkyrinG (green) show the reduction in Caspr 830 
dimer number flanking ankyrin G clusters with diminishing glycolipid expression. Scale bar = 10 μm. 831 
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 832 
Figure 6. Glycolipid deficiency causes pathological changes and compromises CNS axon survival and 833 
function. A) Representative ultrastructural features observed in CST-/- x GD3s-/- and CST-/- x GalNAc-T-834 
/- mice. Normal myelinated axon (magenta arrowhead), degenerating axons (white arrowheads), 835 
dark condensed degenerating axon (white arrow), vacuoles within axons (*), empty myelin sheath 836 
(magenta arrow), redundant myelin (blue arrow), abnormal cytoskeleton (green arrowhead), 837 
microglia (MG). B) Electron micrographs depict the differences among the genotypes: white 838 
arrowheads indicate degenerating axons. Myelin is similar among mouse lines. C) Degenerating axon 839 
number increases to a significant level compared to wild type in optic nerves from CST-/-, CST-/- x 840 
GD3s-/- and CST-/- x GalNAc-T-/- mice. Reintroducing a- and b-series gangliosides into neurons rescues 841 
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this pathology. D) A reduction in conduction velocity was observed in optic nerves with diminishing 842 
glycolipid content. This did not reach significance between genotypes. One-way ANOVA followed by 843 
Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as follows: 844 
*p<0.05; **p<0.01; ***p<0.001. Scale bar = 2 μm.  845 
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 846 
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Figure 7. N.B. New order of genotypes. MAG and NF155 expression in the myelin fraction is altered 847 
by glycolipid deficiency. A) In the myelin fraction from P22 brain homogenates, MAG is significantly 848 
reduced in CST-/- x GalNAc-T-/- mice compared to all genotypes, which do not significantly differ from 849 
one another. All genotypes have a significant reduction in MAG expression in whole brain 850 
homogenate compared to WT. Myelin NF155 was significantly reduced in all genotypes compared to 851 
WT (indicated by *) and GalNAc-T-/- (indicated by #), which had similar levels. ^indicates significant 852 
difference between CST-/- x GalNAc-T-/- and CST-/- x GalNAc-T-/--Tg(neuronal) mice. Olig2 is unchanged 853 
by altered glycolipid expression. Representative blots to right of corresponding graphs show protein 854 
intensity per genotype, indicated by the corresponding number in the key below. B) P22 optic nerve 855 
MAG immunostaining is significantly reduced in all genotypes compared to WT nerve, which do not 856 
significantly differ from one another. Representative images show MAG immunostaining per 857 
genotype. Means were calculated per genotype for statistical analysis (one-way ANOVA followed by 858 
Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as follows: 859 
*p<0.05; **p<0.01; ***p<0.001). Scale bar = 50 μm.   860 
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 861 
Figure 8. Schematic depicting the glycolipid rafts and their associated paranodal proteins Caspr, 862 
NF155 and MAG under wild type conditions and in our transgenic mouse lines. GD1a and GT1b are 863 
represented in the ganglioside rafts as they are the major ligands of MAG, however, in reality the 864 
rafts would contain all complex gangliosides. Normally GD1a and GT1b in rafts will tether MAG but in 865 
their absence MAG does not make the axo-glial connection. If NF155 is present, this protein can 866 
partner with Caspr/Contactin to make an axo-glial junction. However, when sulfatide is absent, 867 
NF155 is also lost from the paranode.  In the absence of NF155, Caspr presence is also diminished, 868 
especially with loss of complex ganglioside rafts. Under conditions of both ganglioside and sulfatide 869 
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deficiency, we propose an absence of the structurally supporting proteins MAG and NF155 that 870 
results in the loss of a functionally competent axo-glial junction. 871 
 872 








